Skip to content
Home/Companies/Biotech/Corvidia Therapeutics

Corvidia Therapeutics

Biotech·US·Exited 2020·Held 2yr
Entry
2018
Hold
2yr
Exit
2020

Who owns Corvidia Therapeutics?

Corvidia Therapeutics was owned by Andera Partners through BioDiscovery 5 (2017 vintage) from 2018 to 2020, exited via Trade Sale. Across its history, Corvidia Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Andera Partners
Most recent investor
Andera Partners
BioDiscovery 5 · 2017 · VC
2 ownership periods · full history below

Key facts

HQUnited States
SectorBiotech
Key takeaways
  • ·Fully exited in 2020.
  • ·Average hold across 2 realized cycles: 3 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2020 to .
Co-invest · 2 holders · 2016 · 2020
Sofinnova Partners
Sofinnova PartnersExited 2020
2016 · 2020(4yr) · Sofinnova Capital VIII · 2015 · Life Sciences VC
Trade Sale · to
MOIC
–
Andera Partners
Andera PartnersExited 2020
2018 · 2020(2yr) · BioDiscovery 5 · 2017 · VC
Trade Sale · to
MOIC
–

More from BioDiscovery 5

Other portfolio companies in the same fund.

Amolyt Pharma
Amolyt Pharma
Exited 2024
BiotechFrance· 2021
to
Evommune
Evommune
Exited 2025
BiotechFrance· 2021
to
Nyxoah
Nyxoah
Active
MedTechBelgium· 2020
AgoMab
AgoMab
Exited 2026
BiotechFrance· 2019
to
AM Pharma
AM Pharma
Active
BiotechNetherlands· 2019
Arvelle
Exited 2021
BiotechSwitzerland· 2019
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Corvidia Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Corvidia Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Corvidia Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue